Bacterial vaginosis and aerobic vaginitis as major vaginal microflora balance disorders: Diagnostic and therapeutic characteristics


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To carry out a systematic analysis of the data available in the current literature on the clinical significance and characteristics of the diagnosis and therapy of major vaginal microflora disorders, such as of bacterial vaginosis (BV) and aerobic vaginitis (AV). Material and methods. The review includes the data of foreign and Russian articles published in the past 10 years and found in electron bibliographic databases on this topic. Results. The vaginal microflora balance disorders including BV and AV were described to have a negative impact on female reproductive function. Similarities of and differences between these two conditions were analyzed. Evidence-based approaches to diagnosing and treating BV and AV were given. Conclusion. BV and AV can cause abnormal vaginal discharge and lead to diseases of the genitourinary system and infectious complications of pregnancy. Microscopic vaginal discharge examination is a main laboratory method for the diagnosis of these diseases. Treatment for BV and AV is to inhibit overgrowth of opportunistic bacterial pathogens associated with these conditions.

Full Text

Restricted Access

About the authors

Alevtina Mikhailovna Savicheva

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Email: savitcheva@mail.ru
MD, Professor, Head of Laboratory of Microbiology

Natalia Igorevna Tapilskaya

St Petersburg State Pediatric Medical University

MD, Professor of the Department of Obstetrics and Gynecology

Elena Vasilyevna Shipitsyna

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

PhD, Senior Researcher, Laboratory of Microbiology

Nadezhda Evgenyevna Vorobyeva

D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

Researcher, Department of Endocrinology of Reproduction

References

  1. Tansarli G.S., Kostaras E.K., Athanasiou S., Falagas M.E. Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an under estimated clinical entity. Eur. J. Clin. Microbiol. Infect. Dis. 2013; 32(8): 977-84.
  2. Kenyon C., Colebunders R., Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am. J. Obstet. Gynecol. 2013; 209(6): 505-23.
  3. Bautista C.T., Wurapa E., Sateren W.B., Morris S., Hollingsworth B., Sanchez J.L. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil. Med. Res. 2016; 3: 4.
  4. Allsworth J.E., Peipert J.F. Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am. J. Obstet. Gynecol. 2011; 205(2): 113. e1-6.
  5. Taylor B.D., Darville T., Haggerty C.L. Does bacterial vaginosis cause pelvic inflammatory disease. Sex. Transm. Dis. 2013; 40(2): 117-22.
  6. Donati L., Di Vico A., Nucci M., Quagliozzi L., Spagnuolo T., Labianca A. et al. Vaginal microbial flora and outcome of pregnancy. Arch. Gynecol. Obstet. 2010; 281(4): 589-600.
  7. Haggerty C.L., Totten P.A., Tang G., Astete S.G., Ferris M.J., Norori J. et al. Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex. Transm. Infect. 2016; 92(6): 441-6.
  8. Bradshaw C.S., Morton A.N., Hocking J., Garland S.M., Morris M.B., Moss L.M. et al.High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 2006; 193(11): 1478-86.
  9. Анкирская А.С. Неспецифические вагиниты. Медицина для всех. 2000; 2: 23-28. [Ankirskaya A.S. Non-specific vaginitis. Meditsina dlya vseh. 2000; 2: 23-28. (in Russian)]
  10. Fan A., Yue Y., Geng N., Zhang H., Wang Y., Xue F. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch. Gynecol. Obstet. 2013; 287(2): 329-35.
  11. Jahic M., Mulavdic M., Nurkic J., Jahic E., Nurkic M. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis. Med. Arch. 2013; 67(6): 428-30.
  12. Gondo F., da Silva M.G., Polettini J., Tristao Ada R., Peracoli J.C., Witkin S.S. et al. Vaginal flora alterations and clinical symptoms in low-risk pregnant women. Gynecol. Obstet. Invest. 2011; 71(3): 158-62.
  13. Zodzika J., Rezeberga D., Jermakova I., Vasina O., Vedmedovska N., Donders G. Factors related to elevated vaginal pH in the first trimester of pregnancy. Acta Obstet. Gynecol. Scand. 2011; 90(1): 41-6.
  14. Donders G.G., Van Calsteren K., Bellen G., Reybrouck R., Van den Bosch T., Riphagen I. et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG; 2009: 116(10): 1315-24.
  15. Donders G.G. Definition and classification of abnormal vaginal flora. Best Pract. Res. Clin. Obstet. Gynaecol. 2007; 21(3): 355-73.
  16. Frobenius W., Bogdan C. Diagnostic value of vaginal discharge, wet mount and vaginal pH - an update on the basics of gynecologic infectiology. Geburtshilfe Frauenheilkd. 2015; 75(4): 355-66.
  17. Sobel J.D. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am. J. Obstet. Gynecol. 1994; 171(5): 1215-20.
  18. Donders G., Bellen G., Rezeberga D. Aerobic vaginitis in pregnancy. BJOG. 2011; 118(10): 1163-70.
  19. Massaro G., Scaravilli G., Simeone S., Capuano S., Pastore E., Forte A. et al. Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: our experience. J. Matern. Fetal Neonatal Med. 2009; 22(11): 1063-7.
  20. Rezeberga D., Lazdane G., Kroica J., Sokolova L., Donders G.G. Placental histological inflammation and reproductive tract infections in a low risk pregnant population in Latvia. Acta Obstet. Gynecol. Scand. 2008; 87(3): 360-5.
  21. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991; 29(2): 297-301.
  22. Donders G.G., Ruban K., Bellen G. Selecting anti-microbial treatment of aerobic vaginitis. Curr. Infect. Dis. Rep. 2015; 17(5): 477.
  23. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 1983; 74: 14-22.
  24. Ison C.A., Hay P.E. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex. Transm. Infect. 2002; 78 (6): 413-5.
  25. WHO. Sexually transmitted and other reproductive tract infections. A guide to essential practice. Annex 3. Laboratory tests for STI. Geneva: World Health Organization; 2005.
  26. Menard J.P., Mazouni C., Fenollar F., Raoult D., Boubli L., Bretelle F. Diagnostic accuracy of quantitative real-time PCR assay versus clinical and Gram stain identification of bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29(12): 1547-52.
  27. Cartwright C.P., Lembke B.D., Ramachandran K., Body B.A., Nye M.B., Rivers C.A. et al. Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis. J. Clin. Microbiol. 2012; 50(7): 2321-9.
  28. Kusters J.G., Reuland E.A., Bouter S., Koenig P., Dorigo-Zetsma J.W. A multiplex real-time PCR assay for routine diagnosis of bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 2015; 34(9): 1779-85.
  29. Шалепо К.В., Назарова В.В., Менухова Ю.Н., Румянцева Т.А., Гущин А.Е., Савичева А.М. Оценка современных методов лабораторной диагностики бактериального вагиноза. Журнал акушерства и женских болезней. 2014; 63(1): 26-32. [Shalepo K.V., Nazarova V.V., Menukhova Yu.N., Rumyantseva T.A., Guschin A.E., Savicheva A.M. Evaluation of current methods for laboratory diagnosis of bacterial vaginosis. Zhurnal akusherstva i zhenskih bolezney. 2014; 63(1): 26-32. (in Russian)]
  30. Rumyantseva T.A., Bellen G., Romanuk T.N., Shipulina O.I., Guschin A.E., Shipulin G.A. et al. Utility of microscopic techniques and quantitative real-time polymerase chain reaction for the diagnosis of vaginal microflora alterations. J. Low. Genit. Tract Dis. 2015; 19(2): 124-8.
  31. Федеральные клинические рекомендации по ведению больных бактериальным вагинозом. М.: Российское общество дерматовенерологов и косметологов; 2015. http://www.cnikvi.ru/docs/clinic_recs/infektsii-peredavaemye-polovym-putem/ [Federal clinical recommendations on the management of bacterial vaginosis. Moscow; 2015. http://www.cnikvi.ru/docs/ clinic_recs/infektsii-peredavaemye-polovym-putem/ (In Russian)]
  32. Ferris M.J., Masztal A., Aldridge K.E., Fortenberry J.D., Fidel PL. Jr., Martin D.H. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis. 2004; 4: 5.
  33. De Backer E., Verhelst R., Verstraelen H., Claeys G., Verschraegen G., Temmerman M., Vaneechoutte M. Antibiotic susceptibility of Atopobium vaginae. BMC Infect. Dis. 2006; 6: 51.
  34. De Backer E., Dubreuil L., Brauman M., Acar J., Vaneechoutte M. In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved inbacterial vaginosis. Clin. Microbiol. Infect. 2010; 16(5): 470-2.
  35. Bahar H., Torun M.M., Oçer F., Kocazeybek B. Mobiluncus species in gynaecological and obstetric infections: antimicrobial resistance and prevalence in a Turkish population. Int. J. Antimicrob. Agents. 2005; 25(3): 268-71.
  36. Togni G., Battini V., Bulgheroni A., Mailland F., Caserini M., Mendling W. In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis? Antimicrob. Agents Chemother. 2011; 55(5): 2490-2.
  37. Nyirjesy P., McIntosh M.J., Gattermeir D.J., Schumacher R.J., Steinmetz J.I., Joffrion J.L. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis. Am. J. Obstet. Gynecol. 2006; 194(5): 1277-82.
  38. Tempera G., Abbadessa G., Bonfiglio G.,Cammarata E., Cianci A., Corsello S. et al. Topical kanamycin: an effective therapeutic option in aerobic vaginitis. J. Chemother. 2006; 18(4): 409-14.
  39. Wang C., Han C., Geng N., Fan A., Wang Y., Yue Y. et al. Efficacy of oral moxifloxacin for aerobic vaginitis. Eur. J. Clin. Microbiol. Infect. Dis. 2016; 35(1): 95-101.
  40. Tempera G., Furneri P.M. Management of aerobic vaginitis. Gynecol. Obstet. Invest. 2010; 70(4): 244-9.
  41. Tansarli G.S., Kostaras E.K., Athanasiou S., Falagas M.E. Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur. J. Clin. Microbiol Infect. Dis. 2013; 32(8): 977-84.
  42. Han C., Wu W., Fan A., Wang Y., Zhang H., Chu Z. et al. Diagnostic and therapeutic advancements for aerobic vaginitis. Arch. Gynecol. Obstet. 2015; 291(2): 251-7.
  43. Зырянов С.К., Белоусов Ю.Б. Проблема качества генериков и оценка их соответствия оригинальным препаратам. Клиническая микробиология и антимикробная химиотерапия. 2010; 12(4): 314-20. [Zyryanov S.K., Belousov Yu.B. Quality of generic drug products and equivalence to generic drug products. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya. 2010; 12(4): 314-20. (in Russisn)]
  44. WHO Technical Report Series № 937. 2006. Annex 7: Multisource (Generic) Pharmaceutical Products: Guidelines on registration requirements to establish interchangeability.
  45. Flacco M.E., Manzoli L., Boccia S., Puggina A., Rosso A., Marzuillo C. et al. Registered randomized trials comparing generic and brand-name drugs: a survey. Mayo Clin. Proc. 2016; 91(8): 1021-34.
  46. Соколов А.В. Оригинальные препараты и дженерики: качество, возможные пути решения проблемы. Медицинские технологии. Оценка и выбор. 2012; 3: 52-6. [Sokolov A.V. Original drugs and Generics: Quality, the Possible Methods of Solution of the Problem. Medicinskie tekhnologii. Ocenka i vybor. 2012; 3: 52-6. (in Russian)]

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media